ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ASCO® 2024
06:26

ecancer

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients Undergoing MMUD HCT

FEATURING Monzr Al Malki, Steven Devine
  • 42 views
  • July 24, 2024
09:04

ecancer

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Multiple Myeloma"

FEATURING Xavier Leleu
  • 77 views
  • July 18, 2024
  • 1
40:00

ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

FEATURING Bishal Gyawali
  • 105 views
  • July 2, 2024
  • 1
04:26

ecancer

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local Consolidative Therapy in Limited mNSCLC"

FEATURING Puneeth Iyengar
  • 37 views
  • July 2, 2024
04:35

ecancer

ASCO® 2024 Insights: "Avelumab in Early TNBC With Residual Disease After Neoadjuvant Chemo or at High Risk After Primary Surgery and Adjuvant Chemo"

FEATURING Pierfranco Conte
  • 70 views
  • July 2, 2024
05:26

ecancer

ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials

FEATURING Luis Raez
  • 66 views
  • July 2, 2024
  • 1
03:04

ecancer

ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"

FEATURING Li Zhang
  • 29 views
  • July 2, 2024
  • 1
02:48

ecancer

ASCO® 2024 Insights: "Clinical Behavior and Prognostic Impact of Genetic Testing in Young BRCA Breast Cancer Patients"

FEATURING Matteo Lambertini
  • 83 views
  • July 2, 2024
  • 1
04:11

ecancer

ASCO® 2024 Insights: "INAVO-PBO Trial - 1L Inavolisib/Placebo + Palbo + Fulv in Patients With PIK3CAm, HR+/HER2‑ Locally Advanced/Metastatic BC Who Relapsed During/Within 12 Months of Adjuvant ET Completion"

FEATURING Dejan Juric
  • 131 views
  • July 2, 2024
  • 1
02:54

ecancer

ASCO® 2024 Insights: "MajesTEC-7 Study - Safety and Efficacy of Tec-DR in NDMM"

FEATURING Salomon Manier
  • 67 views
  • June 26, 2024
03:48

ecancer

ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"

FEATURING Natalia Neparidze
  • 73 views
  • June 25, 2024
03:48

ecancer

ASCO® 2024 Insights: "CARTITUDE-4 Study - Benefits of Ciltacabtagene Autoleucel in Lenalidomide-Refractory Functional High-Risk MM"

FEATURING Luciano Costa
  • 109 views
  • June 24, 2024
02:27

ecancer

ASCO® 2024 Insights: "Monitoring Ovarian Function in DeFi Study - Nirogacestat in Desmoid Tumors"

FEATURING Elizabeth Loggers
  • 32 views
  • June 24, 2024
17:44

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evidence on PSA Testing in Prostate Cancer"

FEATURING Friederike Schlürmann, Boris Hadaschik, Karim Fizazi
  • 192 views
  • June 24, 2024
22:22

ecancer

ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HRRm Testing in Patients With Metastatic Prostate Cancer"

FEATURING Martin Schostak, Alexander Wyatt, Charles Ryan, Emmanuel Antonarakis
  • 181 views
  • June 24, 2024
04:40

ecancer

ASCO® 2024 Insights: "PERSEUS Trial - MRD Analysis of Dara + VRd in Transplant-Eligible NDMM"

FEATURING Paula Rodríguez-Otero
  • 64 views
  • June 24, 2024
  • 1
12:37

ecancer

ASCO® 2024 Summary: "IMROZ & BENEFIT Studies in Newly Diagnosed Myeloma"

FEATURING Xavier Leleu
  • 182 views
  • June 24, 2024
  • 1
04:34

ecancer

ASCO® 2024 Insights: "IMROZ - A Ph3 Study of Isatuximab + VRd vs. VRd for Transplant-Ineligible NDMM"

FEATURING Thierry Facon
  • 109 views
  • June 24, 2024
19:33

ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

FEATURING Enriqueta Felip, Alex Spira, Antonio Passaro, Alfredo Addeo
  • 499 views
  • June 21, 2024
  • 1
04:33

ecancer

ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidation Treatment After Concurrent Platinum-Based CRT for LS-SCLC"

FEATURING David Spigel
  • 75 views
  • June 21, 2024
02:26

ecancer

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"

FEATURING Robert Jotte
  • 188 views
  • June 21, 2024
  • 2
02:57

ecancer

ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitive CRT in Patients With Unresectable Stage 3 EGFRm NSCLC"

FEATURING Suresh Ramalingam
  • 62 views
  • June 21, 2024
05:00

ecancer

ASCO® 2024 Insights: "CARACO Trial - Omission of Lymphadenectomy in Advanced Epithelial Ovarian Cancer"

FEATURING Jean-Marc Classe
  • 139 views
  • June 21, 2024
  • 1
06:37

ecancer

ASCO® 2024 Insights: "Final OS & PFS From the AGO-OVAR 2.29/ENGOT-ov34 Study- Atezolizumab vs. Placebo in Combination With Bevacizumab + Chemo in Recurrent Ovarian Cancer"

FEATURING Frederik Marmé
  • 83 views
  • June 21, 2024
01:47

ecancer

ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuvant CRT in Patients With Esophageal Adenocarcinoma"

FEATURING Jens Hoeppner
  • 64 views
  • June 21, 2024
06:13

ecancer

ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

FEATURING Don Dizon
  • 104 views
  • June 21, 2024
  • 1
04:01

ecancer

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abiraterone vs. Abiraterone Alone in mCRPC Post Docetaxel"

FEATURING Christos Kyriakopoulos
  • 45 views
  • June 21, 2024
04:52

ecancer

ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced Lung Cancer - Effective Alternative to In-Person Visits"

FEATURING Joseph Greer
  • 25 views
  • June 20, 2024
  • 1
05:00

ecancer

ASCO® 2024 Insights: "E3311 Trial - Enhancing Oropharynx Cancer Outcomes With Transoral Surgery and Deintensified Post-Op Care"

FEATURING Barbara Burtness
  • 41 views
  • June 20, 2024
04:07

ecancer

ASCO® 2024 Insights: "I-SPY2.2 Trial - Pathologic Response to Neoadjuvant Datopotamab Deruxtecan in Breast Cancer"

FEATURING Jane Meisel
  • 235 views
  • June 20, 2024
02:57

ecancer

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adjuvant Nivo in Stage III Melanoma"

FEATURING Christian Blank
  • 47 views
  • June 20, 2024
  • 1
04:35

ecancer

ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab Govitecan +/- Pembro in MIBC"

FEATURING Antonio Cigliola
  • 46 views
  • June 20, 2024
03:12

ecancer

ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immediate Surgery in Fully Resectable Melanoma"

FEATURING Axel Hauschild
  • 37 views
  • June 20, 2024
04:41

ecancer

ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRPC Patients Treated with Lutetium-177-PSMA-617"

FEATURING Karim Fizazi
  • 79 views
  • June 20, 2024
02:52

ecancer

ASCO® 2024 Insights: "Long-Term Follow-Up of MajesTEC-1 Trial - Teclistamab in R/R MM"

FEATURING Alfred Garfall
  • 24 views
  • June 20, 2024
04:25

ecancer

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

FEATURING Jennifer Knox
  • 196 views
  • June 20, 2024